Loading...
HomeMy WebLinkAbout25N234 - PURDUE & THE SACKLER FAMILYDocusign Envelope ID: B1989F9E-FFFB-4COE-8DE3-5767DA3F4316 New National Opioids Settlement: Purdue Opioids Implementation Administrator opioidsparticipationCcDrubris. com Palm Springs city, CA Reference Number: CL-1731146 TO LOCAL POLITICAL SUBDIVISIONS; THIS PACKAGE CONTAINS DOCUMENTATION TO PARTICIPATE IN THE NEW NATIONAL OPIOIDS SETTLEMENT. YOU MUST TAKE ACTION IN ORDER TO PARTICIPATE. Deadline: September 30, 2025 A new proposed national opioids settlement has been reached with Purdue (and certain of its affiliates) and the Sackler family. This Participation Package is a follow- up communication to the Notice of New National Opioids Settlement recently received electronically by your subdivision. The proposed settlement is being implemented in connection with Purdue's bankruptcy proceedings, and consists of, among other things, a settlement of Purdue's claims against the Sacklers and certain other parties (referred to as the "Purdue Estate Settlement"), and settlements of direct claims against the Sacklers held by States, local governments and other creditors (collectively, the "Purdue Direct Settlement", and together with the Estate Settlement, the "Purdue Settlement"). The Purdue Direct Settlement for States and local governments is documented in the Governmental Entity and Shareholder Direct Settlement Agreement. You are receiving this Participation Package because all eligible States and territories, including California, are participating in the Purdue Direct Settlement. This electronic envelope contains: The Participation Form for the Purdue Direct Settlement, including a release of any claims; and The Proposed California State -Subdivision Agreement Regarding Distribution and Use of Settlement Funds - Purdue/Sackler Settlement ("California State - Subdivision Agreement"), which governs the allocation, distribution, and use of abatement funds from the Purdue Settlement paid to California. The Participation Form and California State -Subdivision Agreement must be executed, without alteration, and submitted on or before September 30, 2025, in order for your subdivision to be considered for initial participation calculations and payment eligibility under the Purdue Direct Settlement. Based upon subdivision participation forms received on or before September 30, 2025, the subdivision participation rate will be used to determine whether Docusign Envelope ID: B1989F9E-FFFB-4COE-8DE3-5767DA3F4316 participation is sufficient for the Purdue Settlement to move forward and whether a state earns its maximum potential payment under the Purdue Direct Settlement. If the Purdue Settlement moves forward and goes effective, your release will become effective. If the Purdue Settlement does not move forward, that release will not become effective. Any subdivision that does not participate in the Purdue Direct Settlement cannot directly share in the Purdue Direct Settlement funds, even if other subdivisions in the state are participating and sharing in those Purdue Direct Settlement funds. Any subdivision that does not participate may also reduce the amount of money for programs to remediate the opioid crisis in its state. Please note, a subdivision will not necessarily directly receive Purdue Settlement funds by participating; decisions on how Purdue Settlement funds will be allocated within a state are subject to intrastate agreements or state statutes. You are encouraged to discuss the terms and benefits of the Purdue Settlement with your counsel, your Attorney General's Office, and other contacts within your state. The State of California, along with a group of cities and counties, negotiated the California State -Subdivision Agreement, which governs the allocation, distribution, and use of abatement funds from the Purdue Settlement paid to California. The allocation of abatement funds will be similar to the allocation in the prior opioids settlements, where the vast majority (85%) of abatement funds is expected to go to local governments. Information and documents regarding the Purdue Settlement, including a complete copy of the Governmental Entity and Shareholder Direct Settlement Agreement, and how it is being implemented in your state and how funds will be allocated within your state can be found on the national settlement website at https://nationalopioidsettlement.com/purdue-sacklers-settlements/. This website will be supplemented as additional documents are created. How to return signed forms: There are three methods for returning the executed Participation Form and any supporting documentation to the Implementation Administrator: (1)Electronic Signature via DocuSign: Executing the Participation Form and California State -Subdivision Agreement electronically through DocuSign will return the signed form and agreement to the Implementation Administrator and associate your form and agreement with your subdivision's records. Electronic signature is the most efficient method for returning the Participation Form and California State -Subdivision Agreement, allowing for more timely participation and the potential to meet higher settlement payment thresholds, and is therefore strongly encouraged. (2)Manual Signature returned via DocuSign: DocuSign allows forms to be downloaded, signed manually, then uploaded to DocuSign and returned automatically to the Implementation Administrator. Please be sure to complete Docusign Envelope ID: B1989F9E-FFFB-4COE-8DE3-5767DA3F4316 all fields. As with electronic signature, returning a manually signed Participation Form and California State -Subdivision Agreement via DocuSign will associate your signed form and agreement with your subdivision's records. (3)Manual Signature returned via electronic mail: If your subdivision is unable tc return an executed Participation Form and California State -Subdivision Agreement using DocuSign, the signed Participation Form and California State - Subdivision Agreement may be returned via electronic mail to opioidsparticipation@rubris.com. Please include the name, state, and reference ID of your subdivision in the body of the email and use the subject line Settlement Participation Form - [Subdivision Name, Subdivision State] - [Reference ID]. Detailed instructions on how to sign and return the Participation Form and California State -Subdivision Agreement, including changing the authorized signer, can be found at https://nationalopioidsettlement.com/purdue-sacklers-settlements/. You may also contact opioidsparticipation@rubris.com. YOU MUST PARTICIPATE IN THE PURDUE DIRECT SETTLEMENT BY RETURNING YOUR PARTICIPATION FORM AND CALIFORNIA STATE - SUBDIVISION AGREEMENT IN ORDER TO RECEIVE THE BENEFITS OF THE PURDUE SETTLEMENT. Please note that this is NOT a solicitation or a request for subdivisions to submit votes on the Purdue bankruptcy plan. This settlement package only pertains to a decision to participate in the Purdue Direct Settlement. If you receive a package to vote on the plan you should follow the applicable instructions for voting. PLEASE NOTE THAT VOTING ON THE PLAN IS SEPARATE FROM PARTICIPATION IN THE PURDUE DIRECT SETTLEMENT. The sign -on period for subdivisions ends on September 30, 2025. If you have any questions about executing the Participation Form, please contact your counsel, the Implementation Administrator at opioidsparticipation@rubris.com, or the California Attorney General's Office at opioidsettlement-localgovernment@doj.ca.gov. Thank you, Implementation Administrator for the Purdue Direct Settlement The Implementation Administrator is retained to provide the settlement notice required by the Purdue Direct Settlement to manage the collection of the participation forms for it. Docusign Envelope ID: B1989F9E-FFFB-4COE-8DE3-5767DA3F4316 EXHIBIT K Subdivision Participation and Release Form Governmental Entity: Palm Springs city State: CA Authorized Signatory: scott c sti 1 es Address1: 3200 E. Tahquitz Canyon way Address 2: City, State, Zip: Palm springs Cal i forni a 92263-2743 Phone: 7603228350 Email: scott.stiles@palmspringsca.gov The governmental entity identified above ("Governmental Entity"), in order to obtain and in consideration for the benefits provided to the Governmental Entity pursuant to that certain Governmental Entity & Shareholder Direct Settlement Agreement accompanying this participation form (the "Agreement")', and acting through the undersigned authorized official, hereby elects to participate in the Agreement, grant the releases set forth below, and agrees as follows. 1. The Governmental Entity is aware of and has reviewed the Agreement, and agrees that by executing this Participation and Release Form, the Governmental Entity elects to participate in the Agreement and become a Participating Subdivision as provided therein. 2. The Governmental Entity shall promptly after the Effective Date, and prior to the filing of the Consent Judgment, dismiss with prejudice any Shareholder Released Claims and Released Claims that it has filed. With respect to any Shareholder Released Claims and Released Claims pending in In re National Prescription Opiate Litigation, MDL No. 2804, the Governmental Entity authorizes the Plaintiffs' Executive Committee to execute and file on behalf of the Governmental Entity a Stipulation of Dismissal with Prejudice substantially in the form found at https:Hnationalopioidsettlement.com. 3. The Governmental Entity agrees to the terms of the Agreement pertaining to Participating Subdivisions as defined therein. 4. By agreeing to the terms of the Agreement and becoming a Releasor, the Governmental Entity is entitled to the benefits provided therein, including, if applicable, monetary payments beginning following the Effective Date. 5. The Governmental Entity agrees to use any monies it receives through the Agreement solely for the purposes provided therein. 6. The Governmental Entity submits to the jurisdiction of the court in the Governmental Entity's state where the Consent Judgment is filed for purposes limited to that court's role as and to the extent provided in, and for resolving disputes to the extent provided in, the ' Capitalized terms used in this Exhibit K but not otherwise defined in this Exhibit K have the meanings given to them in the Agreement or, if not defined in the Agreement, the Master Settlement Agreement. K-1 Wuo Docusign Envelope ID: B1989F9E-FFFB-4COE-8DE3-5767DA3F4316 Agreement. The Governmental Entity likewise agrees to arbitrate before the National Arbitration Panel as provided in, and for resolving disputes to the extent otherwise provided in, the Agreement. 7. The Governmental Entity has the right to enforce the Agreement as provided therein. The Governmental Entity, as a Participating Subdivision, hereby becomes a Releasor for all purposes in the Agreement, including without limitation all provisions of Article 10 (Release), and along with all departments, agencies, divisions, boards, commissions, districts, instrumentalities of any kind and attorneys, and any person in his or her official capacity whether elected or appointed to serve any of the foregoing and any agency, person, or other entity claiming by or through any of the foregoing, and any other entity identified in the definition of Subdivision Releasor, to the maximum extent of its authority, for good and valuable consideration, the adequacy of which is hereby confirmed, the Shareholder Released Parties and Released Parties are, as of the Effective Date, hereby released and forever discharged by the Governmental Entity and its Subdivision Releasors from: any and all Causes of Action, including, without limitation, any Estate Cause of Action and any claims that the Governmental Entity or its Subdivision Releasors would have presently or in the future been legally entitled to assert in its own right (whether individually or collectively), notwithstanding section 1542 of the California Civil Code or any law of any jurisdiction that is similar, comparable or equivalent thereto (which shall conclusively be deemed waived), whether existing or hereinafter arising, in each case, (A) directly or indirectly based on, arising out of, or in any way relating to or concerning, in whole or in part, (i) the Debtors, as such Entities existed prior to or after the Petition Date, and their Affiliates, (ii) the Estates, (iii) the Chapter 11 Cases, or (iv) Covered Conduct and (B) as to which any conduct, omission or liability of any Debtor or any Estate is the legal cause or is otherwise a legally relevant factor (each such release, as it pertains to the Shareholder Released Parties, the "Shareholder Released Claims", and as it pertains to the Released Parties other than the Shareholder Released Parties, the "Released Claims"). For the avoidance of doubt and without limiting the foregoing: the Shareholder Released Claims and Released Claims include any Cause of Action that has been or may be asserted against any Shareholder Released Party or Released Party by the Governmental Entity or its Subdivision Releasors (whether or not such party has brought such action or proceeding) in any federal, state, or local action or proceeding (whether judicial, arbitral, or administrative) (A) directly or indirectly based on, arising out of, or in any way relating to or concerning, in whole or in part, (i) the Debtors, as such Entities existed prior to or after the Petition Date, and their Affiliates, (ii) the Estates, (iii) the Chapter 11 Cases, or (iv) Covered Conduct and (B) as to which any conduct, omission or liability of any Debtor or any Estate is the legal cause or is otherwise a legally relevant factor. 9. As a Releasor, the Governmental Entity hereby absolutely, unconditionally, and irrevocably covenants not to bring, file, or claim, or to cause, assist or permit to be brought, filed, or claimed, or to otherwise seek to establish liability for any Shareholder Released Claims or Released Claims against any Shareholder Released Party or Released Party in any forum whatsoever, subject in all respects to Section 9.02 of the Master Settlement Agreement. The releases provided for herein (including the term "Shareholder Released 14% K-2 Docusign Envelope ID: B1989F9E-FFFB-4COE-8DE3-5767DA3F4316 Claims" and "Released Claims") are intended by the Governmental Entity and its Subdivision Releasors to be broad and shall be interpreted so as to give the Shareholder Released Parties and Released Parties the broadest possible release of any liability relating in any way to Shareholder Released Claims and Released Claims and extend to the full extent of the power of the Governmental Entity to release claims. The Agreement shall be a complete bar to any Shareholder Released Claim and Released Claims. 10. To the maximum extent of the Governmental Entity's power, the Shareholder Released Parties and the Released Parties are, as of the Effective Date, hereby released and discharged from any and all Shareholder Released Claims and Released Claims of the Subdivision Releasors. 11. The Governmental Entity hereby takes on all rights and obligations of a Participating Subdivision as set forth in the Agreement. 12. In connection with the releases provided for in the Agreement, each Governmental Entity expressly waives, releases, and forever discharges any and all provisions, rights, and benefits conferred by any law of any state or territory of the United States or other jurisdiction, or principle of common law, which is similar, comparable, or equivalent to § 1542 of the California Civil Code, which reads: General Release; extent. A general release does not extend to claims that the creditor or releasing party does not know or suspect to exist in his or her favor at the time of executing the release that, if known by him or her, would have materially affected his or her settlement with the debtor or released party. A Releasor may hereafter discover facts other than or different from those which it knows, believes, or assumes to be true with respect to the Shareholder Released Claims or such other Claims released pursuant to this release, but each Governmental Entity hereby expressly waives and fully, finally, and forever settles, releases and discharges, upon the Effective Date, any and all Shareholder Released Claims or such other Claims released pursuant to this release that may exist as of such date but which Releasors do not know or suspect to exist, whether through ignorance, oversight, error, negligence or through no fault whatsoever, and which, if known, would materially affect the Governmental Entities' decision to participate in the Agreement. 13. Nothing herein is intended to modify in any way the terms of the Agreement, to which Governmental Entity hereby agrees. To the extent any portion of this Participation and Release Form not relating to the release of, or bar against, liability is interpreted differently from the Agreement in any respect, the Agreement controls. 14. Notwithstanding anything to the contrary herein or in the Agreement, (x) nothing herein shall (A) release any Excluded Claims or (B) be construed to impair in any way the rights and obligations of any Person under the Agreement; and (y) the Releases set forth herein shall be subject to being deemed void to the extent set forth in Section 9.02 of the Master Settlement Agreement. 0 K-3 0 ► . . Docusign Envelope ID: B1989F9E-FFFB-4COE-8DE3-5767DA3F4316 I have all necessary power and authorization to execute this Participation and Release Form on behalf of the Governmental Entity. DocuSigned by: Off WLS Signature: Name: Scott Stiles Title: city Manager Date: 7/28/202 5 � r 0 K-4 ❑ Docusign Envelope ID: B1989F9E-FFFB-4COE-8DE3-5767DA3F4316 Proposed California State -Subdivision Agreement Regarding Distribution and Use of Settlement Funds Purdue/Sackler Settlement 1. Introduction The State of California` and certain of its cities and counties have reached this proposed agreement (the "California Purdue/Sackler State -Subdivision Agreement" or the "Agreement") to govern the payments made to California in In re: Purdue Pharma L.P., et al, Case No. 19- 23649, pending in the United States Bankruptcy Court, Southern District of New York (the "Purdue Bankruptcy Matter") and pursuant to the related settlement with the Sacklers. This Agreement is proposed to govern the allocation, distribution, and use of payments, including the Statewide Payment Amounts, consisting of Base Payments and Incentive Payments, and Estate Distributions, paid to California pursuant to the Governmental Entity & Shareholder Direct Settlement Agreement ("GESA"), the Master Settlement Agreement ("MSA"), the Thirteenth Amended Joint Chapter 11 Plan of Reorganization of Purdue Pharma L.P. and its Affiliated Debtors (the "Plan"), and the Governmental Remediation Trust Agreement ("GRTA"), and any revisions thereto (collectively, the "Governing Documents"), filed in the Purdue Bankruptcy Matter. For the avoidance of doubt, this Agreement does not apply to payments of attorneys' fees and costs made to California, including any payments to California from the Local Government Costs and Expenses Fund and the State Expenses Fund and payments pursuant to Sections 9.01, 9.02, and 9.03 and Exhibit R of the GESA and Sections 5.9(a) and 5.9(b) of the Plan, unless otherwise noted. Pursuant to Exhibit O, paragraph 4, of the GESA, acceptance of this California State -Subdivision Agreement is a requirement to be an Initial Participating Subdivision. 2. Definitions a) CA Participating Subdivision means a General Purpose Government that is a Participating Subdivision and also (a) a Plaintiff Subdivision; (b) a Primary Subdivision; and/or (c) a Non -Litigating Threshold Subdivision. For the avoidance of doubt, eligible CA Participating Subdivisions are those California Subdivisions listed in Exhibits C (excluding Litigating Special Districts), I, and/or W to the GESA. b) CA Litigating Special District means a Litigating Special District located in California. For the avoidance of doubt, CA Litigating Special District does not include School Districts and certain Health and Hospital Special Districts that fall under a separate creditor group in the Purdue Bankruptcy Plan. ' For purposes of clarity, use of the term "California" refers to the geographic territory of California and the state and its local governments therein. The term "State" or "State of California" refers to the State of California as a governmental unit. Docusign Envelope ID: B1989F9E-FFFB-4COE-8DE3-5767DA3F4316 c) Plaintiff Subdivision means a Subdivision located in California, other than a CA Litigating Special District, that filed a lawsuit, on behalf of the Subdivision and/or through an official of the Subdivision on behalf of the People of the State of California, against one or more Opioid Defendants prior to October 1, 2020. d) Opioid Defendant means any defendant (including but not limited to Alvogen, Inc. Amneal Pharmaceuticals LLC; Apotex Corp., Hikma Pharmaceuticals USA Inc. f/k/a West -Ward Pharmaceuticals Corp.; Indivior Inc.; Viatris Inc. a/k/a Mylan N.V.; Sun Pharmaceutical Industries, Inc.; Zydus Pharmaceuticals (USA) Inc.; Kroger Co., Teva Pharmaceutical Industries Ltd., Allergan Finance, LLC, Allergan Limited, CVS Health Corporation, CVS Pharmacy, Inc., Walgreen Co., Walmart Inc., Johnson & Johnson, Janssen Pharmaceuticals, Inc., Purdue Pharma L.P., Cardinal Health, Inc., Cencora, Inc. f/k/a AmerisourceBergen Corporation, McKesson Corporation, Dr. Richard S. Sackler, Beverly Sackler, Jonathan Sackler, David Sackler, Marianna Sackler, Theresa Sackler, Ilene Sackler Lefcourt, Dr. Kathe Sackler, and Mortimer D.A. Sackler) named in a lawsuit seeking damages, abatement, or other remedies related to or caused by the opioid public health crisis in any lawsuit brought by any state or local government on or before October 1, 2020. 3. General Terms This Agreement is subject to the requirements of the Governing Documents, as well as applicable law, and the Governing Documents govern over any inconsistent provision of this California Purdue/Sackler State -Subdivision Agreement. Terms not otherwise defined herein shall have the same meaning as in the Governing Documents. All payments made to the State of California and CA Participating Subdivisions subject to this Agreement will be used for Opioid Remediation, except as allowed by Section 5.02(b) of the GESA and Section 4.01(f)(ii) of the MSA. This Agreement does not apply to funds received by California for attorneys' fees and cost, including payments from the Local Government Costs and Expenses Fund or the State Expenses Fund, unless otherwise noted. 4. State Allocation Funds allocated to California shall be combined pursuant to this Agreement, and 15% of that total shall be allocated to the State of California (the "State of California Allocation"), 70% to the California Abatement Accounts Fund ("CA Abatement Accounts Fund"), and 15% to the California Subdivision Fund ("CA Subdivision Fund"). A. State of California Allocation Fifteen percent of the payments to California subject to this Agreement will be allocated to the State and used by the State for future Opioid Remediation. i Docusign Envelope ID: B1989F9E-FFFB4COE-8DE3-5767DA3F4316 B. CA Abatement Accounts Fund i. Allocation of CA Abatement Accounts Funds a) Seventy percent of the payments to California subject to this Agreement will be allocated to the CA Abatement Accounts Fund. The funds in the CA Abatement Accounts Fund will be allocated based on the allocation model developed in connection with the proposed negotiating class in the National Prescription Opiate Litigation (MDL No. 2804), as adjusted to reflect only those cities and counties that are eligible, based on population or litigation status, to become a CA Participating Subdivision. The percentage from the CA Abatement Accounts Fund allocated to each CA Participating Subdivision is set forth in Appendix 1 in the column entitled abatement percentage (the "Local Allocation"). For the avoidance of doubt, CA Litigating Special Districts and California towns, cities, and counties with a population less than 10,000 (except those that are Plaintiff Subdivisions) are not eligible to receive an allocation of CA Abatement Accounts Funds. b) A CA Participating Subdivision that is a county, or a city and county, will be allocated its Local Allocation share as of the date on which it becomes a Participating Subdivision, and will receive payments as provided in the Governing Documents and this Agreement. c) A CA Participating Subdivision that is a city will be allocated its Local Allocation share as of the date on which it becomes a Participating Subdivision. The Local Allocation share for a city that is a CA Participating Subdivision will be paid to the county in which the city is located, rather than to the city, so long as the county is a CA Participating Subdivision; provided, however, that if a city currently receives direct payment of its share of funds in the National Opioids Settlement with Distributors Cencora, Inc. (f/k/a AmerisourceBergenCorporation), Cardinal Health, Inc., and McKesson Corporation (the "Distributors Settlement"), that city's Local Allocation amount will be paid directly to the city. A Local Allocation share allocated to a city but paid to a county is not required to be spent exclusively for abatement activities in that city, but will become part of the county's share of the CA Abatement Accounts Funds, which will be used in accordance with Section 4.B.ii (Use of CA Abatement Accounts Funds). d) A city within a county that is a CA Participating Subdivision may opt in or out of direct payment at any time, and it may also elect direct payment of only a portion of its share, with the remainder going to the county, by providing notice to the Settlement Administrator at least 60 days prior to a Payment Date. e) The State will receive the Local Allocation share of any payment that is attributable to a county or city that is eligible to become a CA Participating Subdivision, but has not, for a particular payment, become a Participating Subdivision. f) Funds received by a CA Participating Subdivision, and not expended or encumbered within five years of receipt and in accordance with the Governing Documents and this P � 3 Nil Docusign Envelope ID: B1989F9E-FFFB-4COE-8DE3-5767DA3F4316 Agreement shall be transferred to the State; provided however, that CA Participating Subdivisions have seven years to expend or encumber CA Abatement Accounts Funds designated to support capital outlay projects before they must be transferred to the State. ii. Use of CA Abatement Accounts Funds a) The CA Abatement Accounts Funds will be used for future Opioid Remediation in one or more of the areas described in the List of Opioid Remediation Uses, which is Exhibit E to the GESA. b) In addition to this requirement, no less than 50% of the funds received by a CA Participating Subdivision from the CA Abatement Accounts Fund in each calendar year will be used for one or more of the following High Impact Abatement Activities: (1) the provision of matching funds or operating costs for substance use disorder facilities within the Behavioral Health Continuum Infrastructure Program; (2) creating new or expanded Substance Use Disorder ("SUD") treatment infrastructure; (3) addressing the needs of communities of color and vulnerable populations (including sheltered and unsheltered homeless populations) that are disproportionately impacted by SUD; (4) diversion of people with SUD from the justice system into treatment, including by providing training and resources to first and early responders (sworn and non -sworn) and implementing best practices for outreach, diversion and deflection, employability, restorative justice, and harm reduction; (5) interventions to prevent drug addiction in vulnerable youth, including but not limited to, youth in foster care, juvenile justice -impacted youth, youth experiencing adversities related to socioeconomic status, and unhoused youth; and/or (6) the purchase of naloxone for distribution and efforts to expand access to naloxone for opioid overdose reversals. c) The California Department of Health Care Services ("DHCS") may add to this list (but not delete from it) by designating additional High Impact Abatement Activities. DHCS will make reasonable efforts to consult with stakeholders, including the CA Participating Subdivisions, before adding additional High Impact Abatement Activities to this list. d) For the avoidance of doubt, and subject to the requirements of the Governing Documents and applicable law, CA Participating Subdivisions may form agreements or ventures, or otherwise work in collaboration with, federal, state, local, tribal or private sector entities in pursuing Opioid Remediation activities funded from the CA Abatement Accounts Fund. Further, provided that all CA Abatement Accounts Funds are used for Opioid Remediation consistent with the Governing Documents and this Agreement, a county and Oto y 4 Docusign Envelope ID: B1989F9E-FFFB-4COE-8DE3-5767DA3F4316 any cities or towns within the county may agree to reallocate their respective shares of the CA Abatement Accounts Funds among themselves, provided that any direct distribution may only be to a CA Participating Subdivision and any CA Participating Subdivision must agree to their share being reallocated. iii. CA Abatement Accounts Fund Oversight a) Pursuant to Section 5 below, CA Participating Subdivisions receiving funds pursuant to the Purdue Bankruptcy Plan and related Sackler settlement must prepare and file reports annually regarding the use of those funds. DHCS may regularly review the reports prepared by CA Participating Subdivisions about the use of CA Abatement Accounts Funds for compliance with the Governing Documents and this Agreement. b) If DHCS determines that a CA Participating Subdivision's use of CA Abatement Accounts Funds is inconsistent with the Governing Documents or this Agreement, whether through review of reports or information from any other sources, DHCS shall send a request to meet and confer with the CA Participating Subdivision. The parties shall meet and confer in an effort to resolve the concern. c) If the parties are unable to reach a resolution, DHCS may conduct an audit of the Subdivision's use of the CA Abatement Accounts Funds within one year of the request to meet and confer, unless the parties mutually agree in writing to extend the meet and confer time frame. d) If the concern still cannot be resolved, the State may bring a motion or action against the Subdivision in the court where the State has filed its Consent Judgment to resolve the concern or otherwise enforce the requirements of the Governing Documents or this Agreement. However, in no case shall any audit be conducted, or motion be brought, as to a specific expenditure of funds, more than five years after the date on which the expenditure of the funds was reported to DHCS, in accordance with this Agreement. e) Notwithstanding the foregoing, this Agreement does not limit the statutory or constitutional authority of any state or local agency or official to conduct audits, investigations, or other oversight activities, or to pursue administrative, civil, or criminal enforcement actions. C. CA Subdivision Fund i. Fifteen percent of the payments to California subject to this Agreement will be allocated to the CA Subdivision Fund. All funds in the CA Subdivision Fund will be allocated among the Plaintiff Subdivisions that are Initial Participating Subdivisions. The funds will be used, subject to any limits imposed by the Governing Documents and this Agreement, to fund future Opioid Remediation and reimburse past opioid-related expenses, which may include fees and expenses related to litigation. Docusign Envelope ID: B1989F9E-FFFB-4COE-8DE3-5767DA3F4316 However, in no event shall more than one-third (5% out of the 15%) be used for litigation -related fees and expenses. D. Provision for State Back -Stop Agreement On August 6, 2021, Judge Dan Polster of the U.S. District Court, Northern District of Ohio, Eastern Division, issued an order (ECF Docket Number 3814) ("MDL Fees Order") in the National Prescription Opiate Litigation (MDL No. 2804) "cap[ping] all applicable contingent fee agreements at 15%." Private counsel representing Plaintiff Subdivisions should seek its contingency fees and costs from the Local Government Costs and Expenses Fund pursuant to the Governing Documents, and if applicable, the Attorney Fee Fund or Cost Funds under the settlement agreements with other Opioid Defendants. A Plaintiff Subdivision may separately agree to use up to one-third (5% out of the 15%) of its share of the CA Subdivision Fund to pay for fees or costs incurred by its contingency -fee counsel ("State Back -Stop Agreement"), pursuant to Exhibit R of the GESA and the MDL Fees Order, so long as: (1) such payments, together with any payments to contingency -fee counsel from the Local Government Costs and Expenses Fund related to such Plaintiff Subdivision, do not exceed 15% of a Plaintiff Subdivision's total gross recovery under this Agreement; and (2) Plaintiff Subdivision certifies that any payments made under a State Back -Stop Agreement will be made in accordance with the 95% Opioid Abatement use requirements under Section 5.02(a) of the GESA and Section 4.01(f)(i) of the MSA. Before seeking fees or litigation costs and expenses from a State Back -Stop Agreement, private counsel representing Plaintiff Subdivisions must first seek contingency fees and costs from the Local Government Costs and Expenses Fund funded pursuant to the Governing Documents. Further, private counsel may only seek reimbursement for litigation fees and costs that have not previously been reimbursed through prior settlements or judgments. To effectuate a State Back -Stop Agreement pursuant to this section, an agreement in the form of Appendix 2 may be entered into by a Plaintiff Subdivision, private counsel, and the California Office of the Attorney General. The California Office of the Attorney General shall, upon the request of a Plaintiff Subdivision, execute any agreement executed by a Plaintiff Subdivision and its private counsel if it is in the form of Appendix 2. The California Office of the Attorney General will also consider requests from Plaintiff Subdivisions to execute and enter into agreements presented in other forms. For the avoidance of doubt, this Agreement does not require a Plaintiff Subdivision to request or enter into a State Back -Stop Agreement, and no State Back -Stop Agreement shall impose any duty or obligation on the State of California or any of its agencies or officers, including without limitation the Attorney General. s Docusign Envelope ID: B1989F9E-FFFB-4COE-8DE3-5767DA3F4316 5. State and Subdivision Reporting a) DHCS will prepare an annual written report regarding the State's use of funds from the settlement until those funds are fully expended and for one year thereafter. These reports will be made publicly available on the DHCS web site. b) Each CA Participating Subdivision that receives payments of funds from the Purdue Bankruptcy Plan and related Sackler settlement will prepare written reports at least annually regarding the use of those funds, until those funds are fully expended and for one year thereafter. These reports will also include a certification that all funds that the CA Participating Subdivision has received through the Purdue Bankruptcy Plan and related Sackler settlement have been used in compliance with the Governing Documents and this Agreement. The report will be in a form reasonably determined by DHCS. Prior to specifying the form of the report DHCS will confer with representatives of the Plaintiff Subdivisions. c) The State and all CA Participating Subdivisions receiving CA Abatement Accounts Funds will track all deposits and expenditures. Each such subdivision is responsible solely for the CA Abatement Accounts Funds it receives. A county is not responsible for oversight, reporting, or monitoring of CA Abatement Accounts Funds received by a city within that county that receives direct payment. Unless otherwise exempt, Subdivisions' expenditures and uses of CA Abatement Accounts Funds and other payments will be subject to the normal budgetary and expenditure process of the Subdivision. d) Each Plaintiff Subdivision receiving CA Subdivision Funds will track all deposits and expenditures, as required by the Governing Documents and this Agreement. Among other things, Plaintiff Subdivisions using monies from the CA Subdivision Fund for purposes that do not qualify as Opioid Remediation must identify and include in their annual report, the amount and how such funds were used, including if used to pay attorneys' fees, investigation costs, or litigation costs. Pursuant to Section 5.02(b) of the GESA and Section 4.01(f)(ii) of the MSA, such information must also be reported to the Settlement Administrator and Sackler Parties' Representative. e) In each year in which DHCS prepares an annual report DHCS will also host a meeting to discuss the annual report and the Opioid Remediation activities being carried out by the State and Participating Subdivisions. 6. Miscellaneous a) The State or any CA Participating Subdivision may bring a motion or action in the court where the State has filed its Consent Judgment to enforce the requirements of this California Purdue/Sackler State -Subdivision Agreement. Before filing such a motion or action the State will meet and confer with any CA Participating Subdivision that is the subject of the anticipated motion or action, and vice versa. Docusign Envelope ID: B1989F9E-FFFB-4COE-8DE3-5767DA3F4316 b) Except as provided in the Governing Documents, this California Purdue/Sackler State - Subdivision Agreement is not enforceable by any party other than the State and the CA Participating Subdivisions. It does not confer any rights or remedies upon, and shall not be enforceable by, any third party. c) Except as provided in this Agreement, if any provision of this Agreement or the application thereof to any person, entity, or circumstance shall, to any extent, be invalid or unenforceable, the remainder of this Agreement, or the application of such provision to persons, entities, or circumstances other than those as to which it is invalid or unenforceable, will not be affected thereby, and each other provision of this Agreement will be valid and enforceable to the fullest extent permitted by law. d) Except as provided in the Governing Documents, this Agreement shall be governed by and interpreted in accordance with the laws of California. Docusign Envelope ID: B1989F9E-FFFB-4COE-8DE3-5767DA3F4316 The undersigned, Palm Springs city, CA, ACKNOWLEDGES acceptance of this Proposed California State -Subdivision Agreement Regarding Distribution and Use of Settlement Funds - Purdue/Sackler Settlement is a requirement to be an Initial Participating Subdivision and ACCEPTS this Proposed California State -Subdivision Agreement Regarding Distribution and Use of Settlement Funds - Purdue/Sackler Settlement. I swear under penalty of perjury that I have all necessary power and authorization to execute this agreement on behalf of the Governmental Entity. DocuSigned by: Signature: S(# NI's Name: scott stiles Title: city Manager Date: 7/28/2025 9 cqs v - � 0 �^' � � o � cod �o anat m`" C's w o o a cql a) 0 C' �01 0= v, 2 0 U ° U a Cd a) a� o 0 o 0 ate' -0 o o 0 0 o to �•o czo ° d o O O Q. o ... .., cd ai a) .. o ,� o ,�, v m N QUA cd cd U ' y cU O 'd c� _ oo _O ¢. � O 0 cm O O 0 0 S 'C Cd 'C `5 O cd y cn O A + C) bUA o J N cl oa, o `� cd a, > 'd �;a ao ' cl r as' o cd bn o V cl Cd 0 � ' a, 'o o o .> o U -� -" d -15 o a ;.teabnw a, to o 4� 0 *' 0o �o. -d c �.° 00o � >0 .o d o O rA " o o a� o a' • o - a' o a�i a� c> u a�i o o 0 o ¢, C o O > o a .o .0 cz 'cz � n v 0 o o ° o °° t 4, : - O ai , y 0; 0 o. 0 Cj N O 4-4 > o b 0o o vo 3 v� w 4-4 o 04 a v o 3 a, t ' = a, � . ° � o. A" o �, o o a nZI UrA�'� o .��•�b �b o 00 CAo " o 0 0 0 0 o e o 0 o e e o 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ^O C bA N N 00 Zo O in "o 00 O Zo "T t- t- et kA 00 0� kn � ,..i V7 ON 0� O I�o kn It M 00 00 t- O� 01, 'RT N 00 t- tM �o t` m N t- �'q -Z t- �o o0 t- t N t` �z �o O M N 'I oo "m 'I kn � N M 00 M O �o N O N � t 000 M O e} M do 00 "T tn •�-� N in � 00 et et to 0 'T O to o0 do r- 3 Q y N U i N M 00 Q� rt N O V i M M M M 00 M N O O O N O O O O O O O C O O O O 1 O I O 46�4 O O O O N O 0 0 0 0 I 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 C N a1 M N M M 00 � d - t` a, M �O kn�� O O �n M N O V) N 00 -� �O M"t N N v', O M N O to N 0 +�- v M O O 0 0- O O � O O O O N 00 cd m m« 3 m m cC m m m m m m m m v, O un O rn O 'A O 'A O CIO O rn O � O ^O ^d 7C 7d N ^O N ^d N b N ^b N y� c�S U U U U U U U U cd N � N N N N b- O cd s. cC �. cd s, cd i. cd �, cd cd cd o cd c� mcd cC cC cd cd cd cd cC cd cd cd cd G� (.� CQ ki Q Q Q Q Q Q Q Q Q Q Q Q Q U O O O O O O O O U U U U U U U U o � y y a b a� _ vp Q> u rQ� O L% Q c.% O O UO cl a, �� Qcl ?y �dcAUUQWx aQQaaQwr�xzOa e� a 0 o. 'S 0 0 0 U U U U U U U U U U U U U o U U U U U U U 5 U U U U U Q) o_ 0 m c W c m N L) O O M �1 Q z w a a) a 0 m c W c m N U O 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 G C O M t- �o t- 01 C\ CN IT M all N 00 I N 1�0 O ,..i rt to d• t-- t'- t-- Ifs It tn t-- 00 tn r M a� O�o tfi O �o O t IT W) M O M'T to to O M B 00 O to O M M t- 00 W) C� M m T 00 'T .-+ Z O 14 mT VtV to �z to rr M 4 t- = to a\ \D r-+ oA v �D 00 a1 00 O �C �D 00 �D N D1 O t-- W) M 00 C1 kn C� 00 �Z t- M C� M t-- M ...i M 00 00 C', t` 'T M �o Cs 'T 3 T N kn O N Cs O O M 0 0 0 0 0 0 0 0 0 0 C S C •� '� u � rn a O O N O - v] a aQi e� o 0 N_ 0 d 0 O 0 vl� 0 M 0 M 0 cn 0 �.c 0 00 0 0 � 0 It 0 OC 0 kn 0 •-+ 0 kn 0 v1 0 N 0 t� 0 Vn 0 OC 0 N 0 0 OC 0 N 0 00 0 to 0 r- 0 O N N "O — OC O — C1 O O O O O— — — O M R u 0 0 0 0 0 C 0 0 0 0 0 t-- O O OC O O M 0 0 0 0 00 0 0 O cC c3 cd cC cd cd cd cd c� c0 c� c3 0 0 0 0 0 0 0 0 0 0 0 0 p b O U U U U U U U U U U U U 0 ��..,�..� 0 t~ 0 0 0 ^ O t~ 0 0 O 0 i-4 0 Ci 0 z= O p C � m c� m m m m m cC M a,M z O O O v m n Q L. .-- i-. �-- i•. �--• i. �+ i. +-- L. �--• i. r-- Y. r-- L. r.- L. �-•, L+ +.+ L. •� Q Q Q O �, � Yti O i•, O �.. O L. O 3.. p L. O L. �.% i.. O i•. p i•r N i•. 'T", w 0 0 0 0 0 0 0 0 0 0 0 0 C� w w w x U U U U U U U U U U U U c o U N O f 'C O O O O n cd O r s. m O O O 7 M y o .� M U � �' o • _, c� O U o - o a � 0 0 a �a. �' .2 Y o 0 0 ;0 u �. � 0 �a"c��"�' � c, n" ra° ti a �3�q o a of as •� a q w CA cc � a o 0 U U U U U U U U U U U U U o U U U U U U U U U U U U U U b 0 N M 11O O o O O O O O O O O O O O O O O O O O O O O O O O O O Iz IV 14 O o� tn C1 If l- �z tn�o N O Q\ oC r Z C� t- N N 00 C� r- O M M M M O V� V i l� IV N N O [� �O " O N M IV N N N M O l� .�-i O [� O N O r- O O O O O O O O O N O O O O O O O O O O O O O O O O O C OF C s M oc O N cn a 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O r N 00 -- 01 00 � M r- �o N 01 O M V) M 01 00 M l- M l,- IO V ) d, y v - Mkn — Or- - O -- O M O -- -� O O O� O N 00 �y u O- O N O O O O O N O O O O O O O N O 0 0 C [- O O M O L d' A, O O O O O O O O O N O 0 0 0 0 Coco 0 0 6 6 0 0 00 0 6 M It Ri —ct M RS O O O N N U N N O/ N O O cd c� cd a C 0 AM � o 0 cl V o QWw ts d ox ipaUW � Q Sri! -d v3 F� U 'a�U`� m � a ti m U c � y a ou C a o ° p, v O _ U _ U _ U U U U U U U o U U U U U U U U U o U U U U U U U U U y � �' a v Q z w a a d u 0 \ 0 \ 0 \ 0 \ 0 \ 0 \ 0 \ 0 \ 0 \ 0 \ 0 \ 0 \ 0 \ 0 \ 0 \ 0 \ 0 \ 0 \ 0 \ 0 \ 0 0 0 0 0 0 0 0 0 0 '0 Cta "T ON 00 O r- O tM kr� r-4 t— N 00 tn N _0 N [— O V M ' tn O 00 �,D .--i 01 M M O M l— 00 tn I— M IRT 00 0� 00 �O V) 0\ 00 0\ 01 N O\ O O �c Rn 00 OU v u O M l� kn O 00 00 M 00 01 N N O, �O 01 01 00 00 00 'Z 7 O l— u [— M O p„ o 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 N 0 N 0 •� .M- o 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 aka o vesA 0 0 0 0 o V') 0 N 0 M 0 0 0 l� 0 00 0 N 0 0 V) 0 O 0 "C 0 O, 0 N 0 O 0 O 0 'T 0 00 0 0 V) 0 0 N 0 M 0 0 M 0 d' "O �O N O y O M O N N O O "D 0 0— O— O'T N O W O W) O M M M�,c u 0 6 0 0 0 0 0 0 0 0 0 6 0 0 0 C 0 0 0 0 C 0 C 0 0 0 0 0 a s O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O cn Vi V) Vl Vi V] VJ cn cn cn V] �n Vi cn cn cn rn cn cn co� cn cn ct cn U cn 'A Qn V� �J cn � U 5 N 'N � 7; N o dQQQQdddddddddQQQQQ¢�QQdQdddQdd U n v cn cn cn cn rn v, cn 'A rn cn cn cn �n cn cn cn v: cn cn cn �n cn V� CA v, U) yr cn 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 �4 a4 On 5 b CACA CAo In cn C4 Qd >pa �UU UU ODUU c��Q C7C7C7 C a Qd �4m •� UQ w 3x x a o � o 0 R „n. U U U U U U U V U U U U U U U U U U U U U U U U U U U U V U j:w Un MA 0 kn 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 [— In In N 011 C� 0� 14 00 O l- w t� N M IV M M m N O 14 01 1O t- t— 00 C� 0� M IV m � = N V i t� l- N N O = N M M q' O\ �O 'o 00 M N �C M V 14 14 N x qv M M Z1 14 0� N 04 y V7 O a1 V7 O� Q� N [� ti 7 = �t C� O �t O �O 00 tn M " O M " N �z = N C O C C O C O O C O O O N C O 0 0 0 0 0 0 0 0 I O I O I O I O O O o of .y o CQ 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 o O o 0 0 0 0 0 0 0 0 0 0 0 0 00 M 01 M W) O V) N N It O'� V) � N CIA "t �,O IC N N M O d a o 0 0 0 0 0 0 0 0 0 0 o ri o 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 o d d d d d d d d d d d d d d d d d d d d d d d d d d d d d d v V: CIO cnC.1�� VII Ln u �n cn V cn, Cn cn�0 VII cl� cnl V� c cn cn cn�n cn 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ocr cn 4 .� cn O CYa ° cd .� cC N O O y m V, = , n W Cd O m o w °' "" ° 0 ° 0 b -d ° -o It aC13 cz 0 'y V H U U U U U U U U U U U U U U U U U U U U U U U U ) {� p: U 0 0 0 0 0 0 0 0 o a o 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 o �c � �'o r- .-- M �c 'T M Cl it 00 O tr) .-- l- �4 01 N .-- tn � en ee M N a\ �c M V- 4'�T 00 O l- M ON N O N ro 00 �o M 7 N 01 kn C O 00 l� I- 00 00 00 00 ItT �O N Io M It00 M 'RT M M M �o 00 O 00 0*� ..� �z M 00 t- N [- tM [- O� kr) O\ ON r 00 O O l- 00 r-4 1 00 ON 00 N O'�T r- t- W) ON '�T oo M �o O*, M �o 41 O O �c M 0� •4 IZ N �c N l- N [- kn r, 3 y 0 r+ 'o O'.4 N N O O O" 0 0 ON N �z O M 00 N O [� 00 In tM O C O C C O O O O O O O O O O O O O O O O O O O O O O C O C 0 0 0 0 wow o 0 0 0 aQi ewe L p o M 0 rM 0 00 0 (71, 0 N 0 0 00 0 �O 0 O 0 v) 0 O 0 N 0 W 0 N 0 �,C 0 C� 0 M 0 N 0 O" 0 N 0 C� 0 'I 0 kf) 0 O 0 00 0 C� 0 C� 0 It 0 C'� 0 0*) ar O O O- O N O O d N N O o0 00 M M d 0 0 00 0 06 0 00 0 0 0 0 0 0 0 0 u a) Q v u v a� a� a� a� °C3 m c c o o QQQQddd¢�Qddddd¢�ddd tz ct It ° U Ln V)(Acnl cool CAI rA rACA, 'A rA cn rA CA�n V) V)- 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 I c 0 5 0 o o Z c ��U'o Con�,� ct � a CAct ,V) � o� o�- 33 U c'3,Cl) Y� L �I � c o 0 a > U U U U U U U U U _ U U U U U U V U U U U U U U U o R F si u 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O �10 M N to 00 O N �o N O kn 01 M l- kn M 14 V-4 N [- N `o r- O M O 00 tn C, IV IV [- [- r- N �O 00 N O S [- et 00 (VN V i �o M �o C N 00 00 I- N �o O tn M O th o0 V1 [- 00 M o0 [- o0 00 o0 in o0 N 0o M M C., tn W) O 00 �o rI O 11�c N C� r- M M M ON 00 1 00 N 14 O [- 11 M tn M It M I- [- ON �o 0\ M [- ON N �o r-� ki) O T* 00 t O 3 .ter tn N 'I O O�q M O r- 4 O C1 �o in O M ro r- r- r- N N O 4.a p o 0 O 0 0 \ 0 0 01 0 o0 0 C a\ N oo l� N vl •ea 'O u � 00 O CIA O .-� M � M �D -� v� a 0 0 0 0 0 V) M 00 "o Vn r- 01 M l- 00 [- 00 -- M y V) N O N "O `O N 0 0 0 -- O Q-, N O o0 -� l� N O 00 00 N M O 7� ') 'C 'O "d U N U U U U N N N cC 'C cd 'C3 cd 'LS U N N U N N " N U U O O O O O O O O O z z z z z z 0 0 o � r o ° x Lon 4, U c, C7 -o o V U j °� a ocl a° C1 a O Q U Q L CC a o q o 0 'Ell, ell C A U U U U U U U U U U U U U U U U U U U U U U U U U U �O U U U A. U 0 a) a 0 a� c W c m D 0 U O 0 rb ❑ of Q z w a a 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 �c 01 01, Ol� C� tn 00 "T 00 N N d' tn r� d' qvqv en C� \c en N �-- 01 00 �--� c a,,kn qv N N O .-- 01 00 0\ qvM O �t O O N qv �Ii M O N O 00 00 oA v N N 00 N en in r- '0 '0 � m F� O 00 �c I kn M tZ� O N N r--� .�-i � W) 1D 'V 01 — O O N O O', "0 " r M C� O 00 �c "" O O O O O C O O C C O O C C O O C O O O O C O C O O •-+ O C O .y ++ 00 N O 00 M V1 O 00 a s o 0 0 0 0 0 0 0 0 v 0 Ilp \° \° \° o 0 0 0 0 0 0 0 0 0 ' o V! 0 1, 0 M 0 l� 0 C� 0 t— 0 It 0 •-- 0 ' - 0 O 0 N 0 N 0 00 0 It 0 a1 0 O 0 a' 0 0 00 0 0o N O W) M 'T d V) ar y �n M M M [� R c� O -- N N� 0 0 0 0 0 0 0 0 O� -- O O O O V1 O O O •--� O O O O O da o0000000000000000000000 000--000 U 0 000 1010101 0 0 0 0 0 0 0 1c,10 0 010 0 0 0 0 0 0 0 0 a a a a Q z cz � "�"� v� > U E "] ¢ U o a c •.. o O cl ,4 O (� cd U C13cz E N 1 w C3,� o v � away w�2 a c on a a o ° w �Ts`="UUUUUUUUUUUUUUUUUUUUUUUUUU oUUU a— 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11 N 14 V..4 �c M O N tn N N d' t` C� O M t� O O O N 4 i p t� V--4 �o M 0� M 00 N t� M O 00 00 4 �o y Io •-+ 1" 1" r-'O O O tn tn N C O el C C C O tO C C O O C O O O O C C C C O O C cO C I C I I O I M o tn wuna .91 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O �--� �O �--� �--� M N � 00 \O M �O O� N oo O C 00 [- y E O M N N "t N O O N M M -- 00 r- O W)"o N 0 0 0 0 Cl 0 — O O O O O O O O O O O O O O N O 0 0 [— � d a U U U U U U U U U U U U U U U y U U U U U U U in cn �n cn 'A cn � � � � cn v, � in cn 'C6 cn in v, cn cn V) cn cn C13� U U U U U U U U U U U U U U U U U U U U U U U U U U U � > > > > > > > > > > > > > > > > > > > > > > > > > U C� rxc c a ac cxacxa!a .> ar�a!as c a ov, � ML U C13 cz > 4 - ram" C C, E Q� i o z � c� �3 �� a o 0 0 Q-0soUUC)000UC. UUUUUUUUUUUUUUUUUUUU w`�'U I� z w In 1.19 pp 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 o 0 0 0 R C1 to O l- en 1-4 tn N �o kn O\ 00 'IT q�t kn N "0 00 O M M M O 00 O 'O O [- q M 01 �o 00 l� c m �o -' M In � �Q �o en O 0o M �o � � O knO � � O� � .� N 00 �z � qT It r- oA c�0 Q tn O M t- rl 00 M M rM ?--i N 0\ 00 ON 11�10 C� O N [- �c O N N O to N N C� [- 00 �Q O 1,0 3 u� 0 00 .-•i O� �--� N 00 O N �--i V i O N Q\ O N O O M� `p � �O � O� N �--i 0 O O O O O O O O M O O O O O O O O O O C C O 0 0 0 0 0 0 0 0 w o � 0 0 0 cl O r� N O I� c� u o0 00 M 00 aai cl o [� 0 O 0 00 0 l- 0 00 0 0 `O 0 [- 0 0*� 0 00 0 V) 0 kn 0 0 -- 0 -- 0 N 0 � 0 k 0 d 0 ON 0 O*, 0 O\ 0 TT 0 r- 0 M 0 00 0 Cl 0 N 0 M 0 ',D y v M O O N O N in O N ,c O M— O M O O M l- 00 kn r- r- O kn M u O O" 0 0 0 0 0 Cl — Cl 0 0 Cl 0 — Cl 0 Cl — 0 0 0 0 a o 0 0 0 0 0 0 o M o C C 0 0 0 0 0 0 C 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ViQ.�yl 0 0 0 0 YQi-�-y11 0 ���iQ--%III 0 0 rV� .0 .0 .Z�e .0 .V .V�}•.1 .V�j.•11 sV}�$ �.�•r•1 .�j--.11I .V� .V}��•1 .V�}••••. .V�..11 .V�.�•.I .V� rV� .V� �" Q� Q--� Q--% ',i...y.lI ',i.•.y11 Sr i8i.. ir (t ia � i. t 7 3.. m i.. m i.. m � i.. 0 ��}.11 t� 1V a ��•.1I j�•.11 �m..1I om E m E E m i.y i.y i•� i.y i-1 i.y i•+ it i•y i-1 i•I i.� i-I i-1 i-1 i.y U W W.y F•,y� W W W.y W.y W.y W.r W W.y W.r 1.•,yl W.y W.y W.y W.y /�N W.y ��\ F•�I rm rm rm rm rci 'm II^ ram^ i. i•4 i•+ i.r i-+ i-1 i-4 i. i-r i•H i.-1 i- i-� i- o :� � � bn V r1 cn `z a; o r o° o b' v o a� 0. ° ti ?? U U ° a ° oCL w C13 •� O o. w u��x �� d U U m V H Lo� `l a; a ao a a o ° U y U U U U U U O41is U U Cc)U U U U U U U U U U U U U U U U U U U U U U a � U Q W a (1) a 0 a� c w c rn .N 0 O 0 0 0 0 0 0 0 0 0 0 0 \ 0 \ 0 \ 0 \ 0 \ 0 \ 0 \ 0 \ 0 \ 0 \ 0 \ 0 0 0 0 0 0 0 0 0 0 C Cta 00 00 kr) �z I'n N 0\ d' M M 00 00 O 0� t- 'T t' 01 0� V �t I O� �O M O N oo N 0\ 00 00 O 00 ON '0 O N qT �O C O �,G �T 01 01 00 tn �4 � N M 00 ++ C N l- -T -1 O in N N N in ON 00 ' O 00 rt V i - M M RT RT N CD v— O\ O" M O N 00 tn M �O M cM 00 00 tn in 0\ M"T N O y N O tn�c kn M M O\ -0 r 00 M M en M M N [— M lqt O M 01 00 0\ It y O M O 0� M ON �z tn . O O� tn tn [- p. O Q; �-• 0 0 0 0 0 0 0 �-- O O O O O O '-- [: O O O O M O 00 O O G to O O C O O O O C O O O O N O I O O I O I M -- 0 0 11 0 0 1 0 11 0 0 C c o v, o 0 0 0 0 0 0 v) 0 M 0 y+ ;d 00 N O� % '� ci N O O d O M O� of) a \ 0 0 0 0 0 0 ON O L 00 O O ovi0000000c000c�0000M•--o00000000 Qa 0 0 0 0 0 0 0 0 0 0 0 0� ... • '� o 4 v a� a> a� a� a� a� a� ' QQQQQQG��lAA�1L1QA�1�1L1(� ...Ua� - ...._ .� .� .............� .......� o 0 0 0 0 0 0. .C6 ° o � ° o ° ° ° o ° � ° 03 un cn � o � r � n cz o j c-C> LZct ti° x C7 ti va ° cnv�� cz o. �AUuUwWwZO d 4 ^o5U 72 JUUUUUUUUUUUUUUUUU UUUUUUUUUU a�'U U gig Ow ry O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O 0\ 13, l� O N � 00 � O� �D � �••� � � � M 00 00 � a1 Q, Q\ M �D � �-•� �; o +U tn 00 N 01 O M 00 00 O M N O M N �4 00 T �c M �O [- Vi [-- V> 140 N O� ++ C 00 D\ pp 00 Vi 00 Q` �••� `C O N 00 �D � 00 00 O Q\ ON 01 M N V> kn 00 00 I M l� O r- 0\ O� N M M �z O �O kn O M N 00 M 00 00 00 O1 O, r N �O N n a y M �•-� � `p .••+ � .-i M r-+ .••i O �•-i �-•i � � � � � � M l� O O M O d' Q� .r O N p.� O O O O �••� O O O O O O O O O O O O O O O �••i O O O� O� O O O O ji S C 00 d 0 0. a -� N cn 0 0 0 0 0 0 0 aO0o M 0 [r— 0 0 0 0 0 0 0 M 0 O 0 It M 0 N 0 M 0 0 0 0 0 0 0 0 1� 0 N 0 00 00 V) i y — N l— [— (14 — N O •--- N W% O -- O N R O O O O O O O O O O O O O O O O 0 0 0 O O O O O O O O O O O O O O O N O C O O O O O o o o 0 0 cC ct cC cM 5 cd M cry cd ctS M m cd cd cd cz cC V � O � Z j �-1 cd cC cC cC c� cd c� c� cC cd c� cd cd cd cd cd � � C/� C/� C/� C/� C/� C/� C/� C/� V1 V1 C/� C/� C/� C/� C/i � � � cd cz cd cti C/� C/� CA CA CA un �V)cnU) •y Q ° tc CIO •�• S G ftj a 'o cz cr-I cr tz V U U cz ° a p 47 O O zs`yUUUU�UUUUUUUUUUUUUUC..) U UUU u;&'U 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 b C 00 O O O� N "m N +C M N \0 O oA M M 00 �T rP M O� et 00 O �O O O 00 ON M O 0 0 ao O O O O N O N 1O O O O O O �-- N O O O O O C C O C GG C O C C C O C G+ C� 0 0 . 0 \ 0 \ 0 0 . \ 0 \ 0 \ 0 \ 0 \ 0 . 0 0 0 0 0 0 0 0 0 1.0 V•) .-+ O\ t l— It M M O M vi M V ) 't �t 00 O IC C', - o" l� 00 N -+ cM O1 �,c O V) 00 N mot• \O O', N W O N " M .--i O N — \C — M W u O O O O O O N O O O l� O O O O O N O N l� 0 O r-+ O — — N O O d CIO 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 C 0 0 00 0 0 � cad c�C cad O., cC d d C 7 �• z= ^• gOOOUUUUUUUUUU ~ O cd c� c� cd cd cd cC cd cd �- �� y s O O O O O O O O O O V ,� -1 ,� �- C/� V] V1 C/] C/� UI C/� (z cz C O cz �^ ¢ U O N O U > oav� �co3Ct: ova ° �v��VU v) v�cn y o�Qw cn >� a bA C C O � 5 � V u U U U U U O U U U U U u U U _O ro r� �' a v a 0 C w C 01 N 7 0 O 0 1.19 G .0 l- O qt N N N r- in kri �z ON M N �o "o [- d' ON O� �o 1 00 r+ oo N o0 �Q N 00 (14 M oA v O O� M 01 N O 00 �o tX tZ " O1 Z l- to O N l- r y 00 N 00 d' 00 't � N 00 M t- O r+ tn r-i .� M N U) t` O � It 00 3 y M � .--� 4 M r- O �--i O te ro Z N T- q do 'T� q O O O M th O [- O O O O� O O O O O O M O N O O 00 O O O O O O O M N O 0 0 [� O� 00 ee 'a � a a M O N O •-� O O� O �1 O �O N \,D 00 W) O V- \,C M ,T N O1 "t "t M r- r . r- � IC N N N 00 ar y 00 00 O— O O o0 O� O 00 O N O O O O O M O N O O 00 0 0 0 C 0 0 0"t- 0 0 0 c� cd aS cC � � � � O � O cC cC cC O O O O v n n ^d O o O O O O A� A O O o y s, O O O O o aoi cot � � � � � ' ' un cn � � � V� r> 0 .y zt R CdDO3zOw�7 � cn R a O � F+ 'C UUUUUUUUUUUU oUUUU oUUUUUUUUUUUU a`"U ❑ ❑ Q 0 0 0 0 0 0 0 0 0 0 0 0 u 0 ea 3 in [� �" I � [- � � rf' th [� � N O O O O O C O O O O O O .y R a�ao 0 0 ► �p - W V) N l— W) oG y Vl N OC V-� V> \.o Vl •-• •— d a o 0 0 0 0 0 0 0 0 0 0 0 > > > > > > � o CtQn c ct o a V��� as a � ell ,) 0G wi R 7 R a V 2 N a O N c W c rn N Z) U O Docusign Envelope ID: B1989F9E-FFFB-4COE-8DE3-5767DA3F4316 APPENDIX 2 CALIFORNIA-SUBDIVISION BACKSTOP AGREEMENT On August 6, 2021, Judge Polster of the US District Court for the Northern District of Ohio issued an Order (the Order), docket number 3814, in In Re National Prescription Opiate Litigation, MDL 2804, addressing contingent attorney fee contracts between political subdivisions eligible to participate in the Purdue/Sackler settlement and their counsel. In light of the Order, and at the request of [SUBDIVISION], the [SUBDIVISION], its counsel [COUNSEL], and the California Attorney General, on behalf of the State of California, are entering into this California -Subdivision Backstop Agreement (Backstop Agreement). [SUBDIVISION] and [COUNSEL] intend this Backstop Agreement to constitute a State Back - Stop Agreement as that term is used in the Order and in Exhibit R (Agreement on Attorneys' Fees, Expenses and Costs) of the Governmental Entity & Shareholder Settlement Agreement (GESA). Pursuant to this Backstop Agreement, [SUBDIVISION] may, subject to the limitations of the Governing Documents and California Purdue/Sackler State -Subdivision Agreement, as well as any other limitations imposed by law, use funds that it receives from the CA Subdivision Fund of the Purdue/Sackler settlement to pay a contingent fee to [COUNSEL]. Any such payment from [SUBDIVISION] to [COUNSEL] from [SUBDIVISION'S] CA Subdivision Fund allocation will not exceed [PERCENTAGE NOT TO EXCEED ONE-THIRD OR 5% OUT OF THE 15%] out of the [SUBDIVISION'S] 15% CA Subdivision Fund allocation; provided further that such payments, together with any contingency -fees that [COUNSEL] may receive from the Local Government Costs and Expenses Fund, will not exceed a total contingency fee of [PERCENTAGE NOT TO EXCEED 15%] of the [SUBDIVISION'S] total gross recovery from the Purdue/Sackler settlement. [SUBDIVISION] further certifies that any payments made under this Backstop Agreement will be made in accordance with the 95% Opioid Abatement use requirements under Section 5.02 A of the GESA and Section 4.01(f)(i) of the Master Settlement Agreement. [COUNSEL] certify that they first sought fees and costs from the Local Government Costs and Expenses Fund created under the Governing Documents before seeking or accepting payment under this backstop agreement. [COUNSEL] further certify that they are not seeking and will not accept payment under this backstop agreement of any litigation fees or costs that have been reimbursed through prior settlements or judgments. The Attorney General is executing this agreement solely because the definition of "State Back - Stop Agreement" in Exhibit R of the Governmental Entity & Shareholder Settlement Agreement requires such agreements to be between "a Settling State" and private counsel for a participating subdivision. Neither the California Attorney General nor the State of California have any obligations under this Backstop Agreement, and this Backstop Agreement does not require the payment of any state funds to [SUBDIVISION], [COUNSEL], or any other party. Docusign Envelope ID: B1989F9E-FFFB-4COE-8DE3-5767DA3F4316 [DATE] [DATE] [DATE] [SUBDIVISION SIGNATURE BLOCK] [COUNSEL SIGNATURE BLOCK] [ATTORNEY GENERAL SIGNATURE BLOCK] o��